Agilent, 685975-908K, AdvanceBio HIC, 4.6 × 100 mm, 3.5 µm, method validation kit

AdvanceBio HIC, 4.6 × 100 mm, 3.5 µm, method validation kit. Includes three columns from different batches

Specifications:
Brand: AdvanceBio HIC
Hardware: SS
Inner Diameter (ID): 4.6 mm
LC Platform: Stainless Steel
Length: 30 mm
Maximum Temperature: 60 °C
Part Number Application Domain: Biopharma
Particle Size: 3.5 µm
Particle Type: Fully Porous
Pore Size: 450 Å
Pressure Rating: 400 bar
Separation Mode: Hydrophobic Interaction (HIC)
Shipping Solvent: Acetonitrile
UNSPSC Code: 41115709
pH Range: 2-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio HIC 4.6 x 100 mm 3.5 µm method validation kit is specifically engineered for the robust and efficient analysis of biomolecules using hydrophobic interaction chromatography. This kit supports critical method development and validation processes for protein and mAb characterization by providing reproducible separations and high sensitivity. Suited for both research and quality control settings, it enables the precise detection of protein variants, aggregates, and charge-based impurities in biopharmaceutical workflows.

Designed for seamless integration with Agilent HPLC and UHPLC systems, this column kit ensures compatibility with a broad range of leading chromatography instrumentation and related AdvanceBio columns. Its optimized particle size and column dimensions offer excellent resolution and throughput, making it suitable for comprehensive analytical tasks such as batch-to-batch comparability studies, stability testing, and product release assessment. The method validation kit includes supporting documentation and quality assurance data to streamline regulatory compliance and facilitate transfer across laboratories. With its reproducible performance and robust construction, this kit is ideal for researchers and analysts engaged in the development, validation, or routine monitoring of biotherapeutics and protein-based drugs, supporting reliable and high-quality chromatographic data generation.